July 8th 2025
Carlos Chacon, OD, MSc, FIACLE, cited economic and geographic barriers and nonstandardized education as the major barriers keeping patients from adequate eye care in Latin America.
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (CME Credit)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (COPE Credit)
View More
Retina Specialists: Join us in Long Beach
July 31, 2025 - August 2, 2025
Register Now!
The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights
August 27, 2025
View More
SimulatED™: Pioneering Treat-and-Extend Therapy—The Impact of Early Application
View More
3rd Annual IKA Keratoconus Symposium: Front to Back and Everything in Between
September 6, 2025
Register Now!
Clinical Consultations™: Novel Therapeutic Targets in Neovascular Retinal Diseases – A Focus on the Roles of VEGF-C/D
View More
EyeCon 2025
September 26-27, 2025
Register Now!
Optometrists: Earn COPE CE Credits in Portland or Virtually
October 16-17, 2025
Register Now!
Join us at The Ophthalmology Meeting in Orlando this October
October 18, 2025
Register Now!
Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (Cope Credit)
View More
Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (CME Track)
View More
(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care
View More
Expert Perspectives on Technological Advances in Cataract Surgery
View More
Expanding Treatment Options for Demodex Blepharitis: Patient-Centric Approaches to Therapy
View More
Burst CME™ Part 3: Initiating Early Intervention in Patients With Glaucoma Who Fail Pharmacological Therapy
View More
(CME Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes
View More
(CME Track) Burst CME™ Part 1: Insights Into Glaucoma and the Need for Early Intervention
View More
Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs
View More
(COPE Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes
View More
(CME Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention
View More
(COPE Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention
View More
(CME Track) Leveraging Rho Kinase Inhibition in Glaucoma Management — How Can Novel Treatment Pathways Impact Patient Outcomes?
View More
(COPE Track) Leveraging Rho Kinase Inhibition in Glaucoma Management — How Can Novel Treatment Pathways Impact Patient Outcomes?
View More
EnVision Summit
February 13-16, 2026
Register Now!
(CME Track) Visionary Approaches: Rethinking Therapeutic and Interventional Glaucoma Management
View More
(CME Track) The TED Perspective: A Multidisciplinary Approach to Thyroid Eye Care
View More
Practical Approaches to Modern Dry Eye Treatment and Management
View More
(COPE Credit) Time Matters in GA: The Impact of Early Detection and Proactive Treatment Approaches
View More
Vision may be restored to 6 left blind by free cataract surgery in India
December 9th 2014Last week, the Associated Press reported that at least 24 people lost vision after undergoing cataract surgery at a free medical camp, but a new report says doctors may be able to restore sight for at least six patients.
The technician’s role with anesthesia: Part II
December 1st 2014In Part I, I discussed the importance of preoperative preparation, including a detailed medical history to insure a safe surgical experience. (See Fall 2014 issue) In this piece, I will cover the specific medications used with anesthesia, how they are used together to achieve the goals for a particular operation, and finally a discussion of aspects of post-operative management.
B+L announce successful Phase 3 study results of new ophthalmic gel
October 31st 2014Bausch + Lomb recently announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo in eliminating inflammation and pain following cataract surgery by study Day 8, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.
Comparing laser-assisted vs. conventional refractive cataract surgery
September 29th 2014Cataract surgery is one of the most commonly performed medical procedures and the leading diagnosis for outpatient surgery visits (3 million) in the U.S. In the past decade, the introductions of presbyopic and toric intraocular lenses (IOLs) have elevated cataract surgery into a refractive procedure. The latest introduction of femtosecond laser-assisted cataract surgery may further improve the predictability and safety of refractive cataract surgery and enhance refractive outcomes.
Omidria receives FDA approval for use in cataract surgery, IOL replacement
June 3rd 2014The U.S. Food and Drug Administration has approved Omeros’ phenylephrine and ketorolac injection, Omidria, for use during cataract surgery and intraocular lens (IOL) replacement to maintain pupil size by preventing intraoperative miosis and to reduce postoperative pain.
Types of cataracts and their underlying conditions
May 31st 2014A cataract is a clouding of the crystalline lens, resulting in vision loss. There are different types of cataracts, and they may be associated with underlying conditions. Understanding the differences between types of cataracts will improve clinical management of your patients.
Promoting practice growth by investing in optical
April 21st 2014I sometimes wonder why, in the rush to build the medical model, so many of my colleagues seemingly abandon the retail aspects of our profession. Many ODs seem to want to forget or diminish that our historical contribution to vision has been mainly centered around the correction, refractive, and binocular vision function and development.
Maximum medical therapy in glaucoma
February 13th 2014A few months ago, I began to see what may be a little more progression on her OCT studies. I’m fairly confident that we’re in a good place right now as far as compliance is concerned, and I’m entering a crossroads with her regarding possibly adding therapy vs. getting a consult for a laser procedure, such as selective laser trabeculoplasty (SLT), vs. getting a cataract consult.
Five pearls for successfully co-managing the premium IOL patient
March 25th 2013The aging baby boom generation could create significant new opportunities for optometrists. ODs are the gatekeepers to cataract referrals and to intraocular lens (IOL) technology. Four out of five cataract diagnoses are made by an optometrist, so referring ODs should make a point of discussing all IOL options with patients.